Sign Up for a Free Account

Andrew Goodman MD

Unit Chief, Rochester Multiple Sclerosis Center

University of Rochester Medical Center

Contributor Disclosures

Dr. Goodman received honorariums as a consultant for Abbvie, Acorda Therapeutics, Atara, Bayer, Biogen-Idec, Celgene, Sanofi Genzyme, Mylan, Novartis, and Purdue. He served as an investigator for contract research with Acorda Therapeutics, Avanir, Biogen-Idec, EMD-Serono, Novartis, Ono, Roche, Sanofi Genzyme, Sun Pharma, and Teva.